Mid- or High-flex Rods Versus Low-flex Rods of SpineShape System IV for Treatment of Degenerative Lumbar Spine Diseases

NCT ID: NCT06320899

Last Updated: 2024-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

126 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-04

Study Completion Date

2031-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this multi-center, randomized, clinical study is to show that the treatment of degenerative lumbar spine with high- or mid-flex rods is not inferior to the treatment with low-flex rods in terms of clinical and safety-related results.

The primary aim is to compare the reduction in back pain after the treatment with high- or mid-flex rods with that after treatment with low-flex rods. Secondary, the functionality after treatment with high- or mid-flex rods will be compared to that after treatment with low-flex rods.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dynamic stabilization systems for the lumbar spine are no novelty. The SpineShape System IV builds on the experience of previous systems and attempts to provide additional benefits primarily through three different and relatively elastic rod stiffnesses. 126 subjects with degenerative symptoms in 1 to 2 segments of the lumbar spine L1 to S1 will be recruited. The participants will be randomized in a 1:1:1 ratio to undergo implantation of either the elastic (experimental product group 1), medium (experimental product group 2) or stiff rod (comparison product group).

The aim of the study is to show that the treatment of degenerative lumbar spine with elastic or medium rod variants is not inferior to treatment with hard rods in terms of clinical and safety-related results. This is checked by completing a questionnaire before the surgical procedure and 3 months, 12 months, 24 months and 60 months after the surgical procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Degenerative Lumbar Spinal Stenosis Facet Joint Arthrosis Spondylarthritis Discopathy Degenerative Spondylolisthesis Instability Lumbar Spine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SpineShape System IV straight rod elastic

Dynamic stabilization of lumbar segments using SpineShape System IV straight rod elastic (high-flex)

Group Type EXPERIMENTAL

SpineShape System IV straight rod elastic

Intervention Type DEVICE

Implantation of SpineShape System IV straight rod elastic

SpineShape System IV straight rod medium

Dynamic stabilization of lumbar segments using SpineShape System IV straight rod medium (mid-flex)

Group Type EXPERIMENTAL

SpineShape System IV straight rod medium

Intervention Type DEVICE

Implantation of SpineShape System IV straight rod medium (mid-flex)

SpineShape System IV straight rod stiff

Dynamic stabilization of lumbar segments using SpineShape System IV straight rod stiff (low-flex)

Group Type ACTIVE_COMPARATOR

SpineShape System IV straight rod stiff

Intervention Type DEVICE

Implantation of SpineShape System IV straight rod stiff (low-flex)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SpineShape System IV straight rod elastic

Implantation of SpineShape System IV straight rod elastic

Intervention Type DEVICE

SpineShape System IV straight rod medium

Implantation of SpineShape System IV straight rod medium (mid-flex)

Intervention Type DEVICE

SpineShape System IV straight rod stiff

Implantation of SpineShape System IV straight rod stiff (low-flex)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* degenerative symptoms in 1 to 2 segments in the lumbar spine L1-S1
* signed informed consent of participant
* confirmation of the participant that the attendance of follow-up visits are intended
* Body-Mass-Index \< 32
* Pedicle screw axis distance \< 30mm
* one or more of the following indications:

* (dynamic) stenosis in the spinal canal
* neuroforaminal stenosis
* facet joint syndrome / spondylarthrosis
* discopathy (recurrent disc hernia)
* degenerative spondylolisthesis (Meyerding \<1)
* instability (hypermobility with antelishtesis, hypomobility with retrolisthesis if decompressed)

Exclusion Criteria

* missing bone structure, e.g. due to congenital anomalies or sever anatomical deformities that make anchoring of the implant impossible
* damaged structural tissue, e.g. due to a bone fracture
* application to the thoracic or cervical spine
* pronounced idiopathic scoliosis
* spondylolisthesis \> Meyerding grad 1
* isthmic spondolylysis
* bone tumor
* osteochondrosis modic type I, II or III
* osteoporosis, which could impair screw anchoring
* history with third party implants
* patients with an active local or systemic infection
* known allergy to titatnium alloys
* skeleton in growth (epiphyseal joints not closed)
* severe muscular neuronal or vascular disease
* immunosuppresive therapy
* long-term therapy with cortisone
* heavy smokers (regular consumption of more than six cigarettes per day), drug addicts and alcoholics
* chronic pain patients
* incapable of judgment or emergency situation
* implantation during pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SpineSave AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philipp Cathrein, Dr.med.

Role: PRINCIPAL_INVESTIGATOR

Hirslanden Klinik Linde

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Spital Aarberg

Aarberg, , Switzerland

Site Status RECRUITING

Hirslanden Klinik Linde

Biel, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sarah Abramovic

Role: CONTACT

+41448669280

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cathrein

Role: primary

+41323668484

Cathrein

Role: primary

+41323668484

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BASEC 2023-D0092

Identifier Type: OTHER

Identifier Source: secondary_id

SpineShape_CH_001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Titanium vs. PEEK Fusion Devices in 1 Level TLIF
NCT05691062 ENROLLING_BY_INVITATION PHASE4
Lumbar Interbody Implant Study
NCT04418830 ENROLLING_BY_INVITATION